Ledger.Open graph →
SEC Form D · filed August 24, 2021

Jnana Therapeutics Inc

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (31)

Caroline S. Beer · Boston, MAExecJoanne D. Kotz · Boston, MAExec · DirectorDonald W. Nicholson · Boston, MADirectorMatthew W. Hammond · Boston, MADirectorCarlo W. Rizzuto · Boston, MADirectorBrian M. Cali · Boston, MADirectorAnnie C. Chen · Boston, MADirectorTerrance G. Mcguire · Boston, MADirectorJoel S. Barrish · Boston, MAExecJohn C. Sykes · NEW YORK, NYExecJohn A. Rogers · New York, NYDirectorBenjamin Lowy · New York, NYDirectorMatt Echols · NEW YORK, NYDirectorThomas Vetrano · NEW YORK, NYDirectorGavin J. Kalin · New York, NYDirectorRadha Swaminathan · NEW YORK, NYExecKevin Strott · Castle Rock, CODirectorMichael Burton · Orleans, INExec · DirectorStuart W. Schreiber · Boston, MADirectorKevin J. Kinsella · La Jolla, CADirectorThomas A. Sargent · Boston, MAExecClark Yuan · Tacoma, WADirectorYaron Shemesh · Englewood Cliffs, NJExecLily Kao · Boston, MADirectorPaul Yoo · PLEASANT HILL, CADirectorReiner Laus · San Diego, CADirectorShivarupam Bhowmik · San Diego, CADirectorJeffrey Friedman · San Diego, CAExec · DirectorFred S. Dillard · Snyder, TXDirectorStuart W. Schreiber · Boston, MADirectorKevin J. Kinsella · La Jolla, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗